@MayoClinic Thoracic Pathology Workshop was held at our university in September. The course provides pathologists, pulmonologists, residents and fellows with key diagnostic, predictive and prognostic information about cancerous and non-cancerous diseases of the thoracic cavity.
It was an honor to welcome Prof. Maleszewski along with other thoracic pathology experts in our institute at the Mayo Clinic Thoracic Pathology Workshop. Thank you for the excellent talks! @joemaleszewski@MayoClinicPath
Examination of genetic background of hereditary cardiac diseases, arrhythmias and aortopathies is now available for hungarian patients in Semmelweis University, Budapest. #cardiogenetics#semmelweisuniversity https://t.co/e7crstbuoN
New advancements in HOCM histology by @joemaleszewski
Myocardial Histopathology in Patients With Obstructive Hypertrophic Ca... https://t.co/meEkxHf3qO
Innovation in molecular diagnostics with a new NGS technology in the Semmelweis University. Hope it will help many patients with cancer or hereditary cardiac diseases.
https://t.co/2N7wE5JYxs
Nation-wide screening for #COVID19#coronavirus led by Semmelweis University attempts to give a clear picture of the #Epidemic's extent in Hungary. Nearly 18,000 people were invited to participate in the #TestingForCovid19 in the upcoming two weeks. https://t.co/FTAANzH47F
#Hydroxychloroquine ≠ benign drug. It can have devastating effect on heart muscle. On the left is normal myocardium. On the right is HcQ-mediated cardiotoxicity with prominent sarcoplasmic vacuolization. #CVPath
Two important dates for your diary:
13th March 2020 UKCPN Annual Meeting & Educational Day in Sheffield
10-12th September biennial @AECVPCam2020 European Association of Cardiovascular Pathology meeting in Cambridge
Lots of great CPD and networking #cardiacpath